Search

Ahshik Kim

Examiner (ID: 13777, Phone: (571)272-2393 , Office: P/2876 )

Most Active Art Unit
2876
Art Unit(s)
2876
Total Applications
2293
Issued Applications
1873
Pending Applications
132
Abandoned Applications
313

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1413726 [patent_doc_number] => 06514518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof' [patent_app_type] => B2 [patent_app_number] => 09/932245 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514518.pdf [firstpage_image] =>[orig_patent_app_number] => 09932245 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/932245
Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof Aug 16, 2001 Issued
Array ( [id] => 5967295 [patent_doc_number] => 20020090343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Expanded perborate salt, use, and method of production' [patent_app_type] => new [patent_app_number] => 09/932766 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5477 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090343.pdf [firstpage_image] =>[orig_patent_app_number] => 09932766 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/932766
Expanded perborate salt, use, and method of production Aug 16, 2001 Issued
Array ( [id] => 6688012 [patent_doc_number] => 20030031737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Medicinal composition and method of using it' [patent_app_type] => new [patent_app_number] => 09/923090 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6294 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031737.pdf [firstpage_image] =>[orig_patent_app_number] => 09923090 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/923090
Medicinal composition and method of using it Aug 5, 2001 Issued
Array ( [id] => 5999356 [patent_doc_number] => 20020028239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Tablet composition' [patent_app_type] => new [patent_app_number] => 09/920830 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3457 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028239.pdf [firstpage_image] =>[orig_patent_app_number] => 09920830 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/920830
Tablet composition Aug 2, 2001 Issued
Array ( [id] => 1406802 [patent_doc_number] => 06524611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-25 [patent_title] => 'Compositions containing creatine and creatinine' [patent_app_type] => B2 [patent_app_number] => 09/917634 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9436 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524611.pdf [firstpage_image] =>[orig_patent_app_number] => 09917634 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/917634
Compositions containing creatine and creatinine Jul 30, 2001 Issued
Array ( [id] => 6687983 [patent_doc_number] => 20030031708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'SYNERGISTIC FILLER COMPOSITION' [patent_app_type] => new [patent_app_number] => 09/915057 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1020 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031708.pdf [firstpage_image] =>[orig_patent_app_number] => 09915057 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/915057
Synergistic filler composition Jul 24, 2001 Issued
09/857795 Medicinal compositions for oral use Jul 18, 2001 Abandoned
09/856585 CAPSULES CONTAINING ONE OR MORE ANTIGENIC SUBSTANCES FOR PREVENTION AND / OR TREATMENT OF AUTO - IMMUNE DISEASES Jul 16, 2001 Abandoned
Array ( [id] => 1316588 [patent_doc_number] => 06605302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Drug delivery device containing oseltamivir and an H1 antagonist' [patent_app_type] => B2 [patent_app_number] => 09/907486 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10139 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605302.pdf [firstpage_image] =>[orig_patent_app_number] => 09907486 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/907486
Drug delivery device containing oseltamivir and an H1 antagonist Jul 16, 2001 Issued
Array ( [id] => 1502459 [patent_doc_number] => 06465010 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Means for creating a mass having structural integrity' [patent_app_type] => B1 [patent_app_number] => 09/902751 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7301 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465010.pdf [firstpage_image] =>[orig_patent_app_number] => 09902751 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/902751
Means for creating a mass having structural integrity Jul 11, 2001 Issued
Array ( [id] => 1362360 [patent_doc_number] => 06565880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea' [patent_app_type] => B2 [patent_app_number] => 09/902822 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5480 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565880.pdf [firstpage_image] =>[orig_patent_app_number] => 09902822 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/902822
Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea Jul 10, 2001 Issued
Array ( [id] => 6274905 [patent_doc_number] => 20020106412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method and materials for controlling migration of binder liquid in a powder' [patent_app_type] => new [patent_app_number] => 09/904190 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9550 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106412.pdf [firstpage_image] =>[orig_patent_app_number] => 09904190 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/904190
Method and materials for controlling migration of binder liquid in a powder Jul 9, 2001 Abandoned
Array ( [id] => 6079958 [patent_doc_number] => 20020081333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Orally administrable opioid formulations having extended duration of effect' [patent_app_type] => new [patent_app_number] => 09/891882 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9354 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081333.pdf [firstpage_image] =>[orig_patent_app_number] => 09891882 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/891882
Orally administrable opioid formulations having extended duration of effect Jun 25, 2001 Issued
Array ( [id] => 1513883 [patent_doc_number] => 06419958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-07-16 [patent_title] => 'Extended release formulation of venlafaxine hydrochloride' [patent_app_type] => B2 [patent_app_number] => 09/884412 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4925 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/419/06419958.pdf [firstpage_image] =>[orig_patent_app_number] => 09884412 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/884412
Extended release formulation of venlafaxine hydrochloride Jun 18, 2001 Issued
Array ( [id] => 1195899 [patent_doc_number] => 06726929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Pharmaceutical mixture comprising a profen' [patent_app_type] => B1 [patent_app_number] => 09/868092 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4287 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/726/06726929.pdf [firstpage_image] =>[orig_patent_app_number] => 09868092 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/868092
Pharmaceutical mixture comprising a profen Jun 13, 2001 Issued
Array ( [id] => 1406922 [patent_doc_number] => 06524618 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Directly compressible extended-release matrix formulation for metformin hydrochloride' [patent_app_type] => B1 [patent_app_number] => 09/879748 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3907 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 458 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524618.pdf [firstpage_image] =>[orig_patent_app_number] => 09879748 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/879748
Directly compressible extended-release matrix formulation for metformin hydrochloride Jun 11, 2001 Issued
Array ( [id] => 7078187 [patent_doc_number] => 20010041165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Effervescent bisphosphonate formulation' [patent_app_type] => new [patent_app_number] => 09/878557 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041165.pdf [firstpage_image] =>[orig_patent_app_number] => 09878557 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/878557
Effervescent bisphosphonate formulation Jun 10, 2001 Abandoned
Array ( [id] => 1154443 [patent_doc_number] => 06761903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Clear oil-containing pharmaceutical compositions containing a therapeutic agent' [patent_app_type] => B2 [patent_app_number] => 09/877541 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25354 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/761/06761903.pdf [firstpage_image] =>[orig_patent_app_number] => 09877541 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/877541
Clear oil-containing pharmaceutical compositions containing a therapeutic agent Jun 7, 2001 Issued
Array ( [id] => 1068423 [patent_doc_number] => 06843983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae' [patent_app_type] => utility [patent_app_number] => 09/875198 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2159 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/843/06843983.pdf [firstpage_image] =>[orig_patent_app_number] => 09875198 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/875198
Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae Jun 6, 2001 Issued
Array ( [id] => 1308318 [patent_doc_number] => 06613358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Sustained-release composition including amorphous polymer' [patent_app_type] => B2 [patent_app_number] => 09/877330 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 22843 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613358.pdf [firstpage_image] =>[orig_patent_app_number] => 09877330 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/877330
Sustained-release composition including amorphous polymer Jun 6, 2001 Issued
Menu